NOCTICKER
Northrop Grumman Corp.
Congress has disclosed 27 buys and 32 sells of NOC (Northrop Grumman Corp.) in official financial disclosures, each linked to its original filing. A transparency record — not investment advice.
Activity Congressional Activity
27
Buy
32
Sell
-5
Net
19
Active politicians
Round-trip watch Still on the books
Members who disclosed buying NOC and have not disclosed selling, versus their own entry (the most recent disclosed buy). "Open" means no disclosed sale — never "still holds" — and the % is unrealised, on paper. Not investment advice.
| Member | Entry (last buy) | Entry price | Now | vs entry | Status |
|---|---|---|---|---|---|
| Alan Armstrong | 2026-03-27 | $672.96 | $557.54 | -17.2% | underwater |
Price as of 2026-10-30. Counted open while disclosed buys outnumber disclosed sells; tracks the price, not exact position size (amounts are ranges).
Price & congressional trades
Buy
Sell
Fundamentals · FY2026 Valuation
Standard valuation multiples from SEC-reported GAAP financials (trailing twelve months), each compared to the median for Defense. We use reported GAAP, not forward or adjusted earnings, so our figures can sit higher than sites that do — especially for companies with falling profit. Relative context — not a target price or investment advice.
P/E
17.52
▼ cheaper than
Defense (median 24.7)
how it's calculated
P/E = price ÷ earnings per share
$557.54 ÷ $31.82 = 17.52
Based on GAAP trailing-twelve-month financials (SEC filings) and the latest close. Other sites may show a different multiple when they use forward (projected) or non-GAAP adjusted figures instead of reported GAAP — for a company with volatile profit those can differ in either direction from the GAAP figure shown here.
P/B
4.24
≈ in line with
Defense (median 4.2)
how it's calculated
P/B = price ÷ book value per share
$557.54 ÷ $131.51 = 4.24
Based on GAAP trailing-twelve-month financials (SEC filings) and the latest close. Other sites may show a different multiple when they use forward (projected) or non-GAAP adjusted figures instead of reported GAAP — for a company with volatile profit those can differ in either direction from the GAAP figure shown here.
EV/EBITDA
14.87
≈ in line with
Defense (median 15.1)
how it's calculated
EV/EBITDA = (market cap + net debt) ÷ EBITDA
($79.2B + $11.5B net debt) ÷ $6.1B = $90.7B ÷ $6.1B = 14.87
Based on GAAP trailing-twelve-month financials (SEC filings) and the latest close. Other sites may show a different multiple when they use forward (projected) or non-GAAP adjusted figures instead of reported GAAP — for a company with volatile profit those can differ in either direction from the GAAP figure shown here.
Legislation Related Legislation
Recent bills in this stock's sector (Defense). Sector-level context from Congress.gov — a bill names a policy area, not this company specifically.
| Bill | Title | Policy area | Latest action |
|---|---|---|---|
| HR 7683 | VA Fiscal Management Modernization Act | Armed Forces and National Security | 2026-10-09 |
| HR 10758 | Veterans Outdoor Rehabilitation Act | Armed Forces and National Security | 2026-10-06 |
| HR 2283 | Recognizing Community Organizations for Veteran Engagement and Recovery Act | Armed Forces and National Security | 2026-10-05 |
| HR 6993 | BEACON Act of 2026 | Armed Forces and National Security | 2026-10-01 |
| HR 10654 | PFB Act | Armed Forces and National Security | 2026-10-01 |
59 trades Recent Congressional Trades
Two things to watch per trade: the disclosure lag (how many days passed before the trade was made public) and the price move in that window (how the stock moved during those non-public days). A sell followed by a price drop, or a buy followed by a rise, means well-timed trading — visible here in the open. Note: the Score measures how notable a trade is, not whether it made money — the price move is shown for context and isn't part of it.
| Politician | Chamber | Type | Owner | Date | Disclosure lag | Price move in that window | Amount | Score | Source |
|---|---|---|---|---|---|---|---|---|---|
| Alan Armstrong | Senate | BUY ◆ insider divergence · moderate | Self | 2026-03-27 | 116 days | -24.2% | $1K–$15K | 82.9 | ↗ eFD |
| Steve Cohen | House | SELL ◆ insider convergence · moderate | Self · Stephens Advantage Account | 2025-12-29 | 16 days | +13.0% | $15K–$50K 0.5% of NW |
98.5 | ↗ filing |
| Valerie Hoyle | House | SELL | Spouse · Fidelity Rollover IRA | 2025-09-23 | 0 days | 0.0% | $1K–$15K 0.8% of NW |
49.2 | ↗ filing |
| Gilbert Cisneros | House | SELL ◆ insider convergence | Self · 150 Main Street Trust > Bank of America | 2025-09-05 | 33 days | +9.8% | $1K–$15K 0.1% of NW |
89.4 | ↗ filing |
| Ritchie John Torres | House | SELL ◆ insider convergence | Self | 2025-07-11 | 21 days | +14.0% | $1K–$15K 3.2% of NW 🔥 |
96.9 | ↗ filing |
| Lisa McClain | House | SELL ◆ insider convergence | Spouse · Charles Schwab Brokerage Account 924 | 2025-06-24 | 50 days | +20.3% | $1K–$15K 0.1% of NW |
33.3 | ↗ filing |
| Lisa McClain | House | BUY ◆ insider divergence | Spouse · Charles Schwab Brokerage Account 924 | 2025-06-17 | 57 days | +15.5% | $1K–$15K 0.1% of NW |
66.7 | ↗ filing |
| Gilbert Cisneros | House | BUY ◆ insider divergence | Self · 150 Main Street Trust > Bank of America | 2025-05-30 | 5 days | +1.8% | $1K–$15K 0.1% of NW |
98.1 | ↗ filing |
| Rob Bresnahan | House | SELL ◆ insider convergence | Self · JP Morgan Brokerage Account | 2025-05-15 | 0 days | 0.0% | $1K–$15K 0.2% of NW |
64.5 | ↗ filing |
| Josh Gottheimer | House | SELL ◆ insider convergence | Joint · Morgan Stanley - Select UMA Account # 1 | 2025-04-09 | 34 days | -8.1% | $1K–$15K <0.1% of NW |
60.4 | ↗ filing |
| Valerie Hoyle | House | BUY ◆ insider divergence | Spouse · Fidelity Rollover IRA | 2024-10-29 | 317 days | +17.7% | $1K–$15K 0.8% of NW |
65.6 | ↗ filing |
| Ritchie John Torres | House | BUY ◆ insider divergence | Self | 2024-09-26 | 309 days | +13.4% | $1K–$15K 3.2% of NW 🔥 |
98.6 | ↗ filing |
| John James | House | SELL ◆ insider convergence | Self · John A. James Children’s Trust | 2024-09-04 | 1 days | -0.8% | $1K–$15K <0.1% of NW |
26.0 | ↗ filing |
| Josh Gottheimer | House | BUY ◆ insider divergence | Joint · Morgan Stanley - Select UMA Account # 1 | 2024-07-19 | 24 days | — | $1K–$15K <0.1% of NW |
62.4 | ↗ filing |
| Jared Moskowitz | House | SELL ◆ insider convergence | Child · Morgan Stanley Active Assets (6) | 2024-07-05 | 26 days | — | $1K–$15K 0.3% of NW |
92.1 | ↗ filing |
| Jared Moskowitz | House | SELL ◆ insider convergence | Self · Morgan Stanley Active Assets (1) | 2024-07-05 | 26 days | — | $1K–$15K 0.3% of NW |
92.1 | ↗ filing |
| Jared Moskowitz | House | SELL ◆ insider convergence | Child · Morgan Stanley Active Assets (5) | 2024-07-01 | 30 days | — | $1K–$15K 0.3% of NW |
98.2 | ↗ filing |
| Josh Gottheimer | House | SELL ◆ insider convergence | Joint · Morgan Stanley - Select UMA Account # 1 | 2024-06-18 | 20 days | — | $1K–$15K <0.1% of NW |
69.0 | ↗ filing |
| Josh Gottheimer | House | BUY ◆ insider divergence | Joint · Morgan Stanley - Select UMA Account # 1 | 2023-12-29 | 6 days | — | $15K–$50K 0.1% of NW |
95.2 | ↗ filing |
| John James | House | BUY ◆ insider divergence | Self · John A. James Children’s Trust | 2023-11-10 | 277 days | — | $1K–$15K <0.1% of NW |
75.9 | ↗ filing |
| Josh Gottheimer | House | BUY ◆ insider divergence | Joint · Morgan Stanley - Select UMA Account # 1 | 2023-09-26 | 15 days | — | $1K–$15K <0.1% of NW |
94.6 | ↗ filing |
| Daniel Goldman | House | BUY ◆ insider divergence | Self · Daniel Goldman Grandchildren 1986 Trust > TACS R3K | 2023-03-06 | 28 days | — | $15K–$50K <0.1% of NW |
99.5 | ↗ filing |
| Lois Frankel | House | SELL | Self · Morgan Stanley IRA - X141 | 2022-10-19 | 30 days | — | $1K–$15K 0.3% of NW |
2.6 | ↗ filing |
| Lois Frankel | House | SELL | Self · Morgan Stanley IRA - X141 | 2022-08-03 | 27 days | — | $1K–$15K 0.3% of NW |
12.3 | ↗ filing |
| Kathy Manning | House | SELL | Joint · Charles Schwab - O'Shaughnessy Asset Management | 2022-08-03 | 34 days | — | $1K–$15K 0.1% of NW |
52.4 | ↗ filing |
| Kathy Manning | House | BUY | Joint · Charles Schwab - O'Shaughnessy Asset Management | 2022-07-20 | 13 days | — | $1K–$15K 0.1% of NW |
75.9 | ↗ filing |
| Lois Frankel | House | SELL | Self | 2022-03-09 | 26 days | — | $1K–$15K 0.3% of NW |
2.6 | ↗ filing |
| Robert Wittman | House | SELL | Self | 2021-12-16 | 4 days | — | $1K–$15K 0.2% of NW |
98.8 | ↗ filing |
| John Yarmuth | House | BUY | Self | 2021-09-23 | 15 days | — | $1K–$15K | 40.4 | ↗ filing |
| Peter Meijer | House | SELL | Self | 2021-02-16 | 3 days | — | $1K–$15K | 40.4 | ↗ filing |
| Peter Meijer | House | SELL | Self | 2021-01-28 | 6 days | — | $1K–$15K | 75.9 | ↗ filing |
| Lois Frankel | House | BUY | Self | 2021-01-13 | 0 days | — | $1K–$15K 0.3% of NW |
2.6 | ↗ filing |
| Lois Frankel | House | BUY | Self | 2020-10-21 | 0 days | — | $1K–$15K 0.3% of NW |
2.6 | ↗ filing |
| John Yarmuth | House | SELL | Self | 2020-06-18 | 21 days | — | $1K–$15K | 75.9 | ↗ filing |
| Lois Frankel | House | BUY | Self | 2019-09-11 | 0 days | — | $1K–$15K 0.3% of NW |
4.5 | ↗ filing |
| Susie Lee | House | BUY | Joint | 2019-01-30 | 0 days | — | $1K–$15K 0.2% of NW |
75.9 | ↗ filing |
| Michael Conaway | House | SELL | Spouse | 2019-01-04 | 4 days | — | $1K–$15K | 2.6 | ↗ filing |
| Michael Conaway | House | BUY | Spouse | 2018-11-02 | 4 days | — | $1K–$15K | 2.6 | ↗ filing |
| Josh Gottheimer | House | SELL | Joint | 2018-10-29 | 7 days | — | $1K–$15K <0.1% of NW |
99.3 | ↗ filing |
| Michael Conaway | House | SELL | Spouse | 2018-10-26 | 4 days | — | $1K–$15K | 12.3 | ↗ filing |
| Barbara Comstock | House | BUY | Self | 2018-08-01 | 2 days | — | $15K–$50K | 90.9 | ↗ filing |
| Michael Conaway | House | SELL | Spouse | 2018-06-21 | 4 days | — | $1K–$15K | 2.6 | ↗ filing |
| Michael Conaway | House | BUY | Spouse | 2018-05-07 | 2 days | — | $1K–$15K | 4.5 | ↗ filing |
| Michael Conaway | House | BUY | Spouse | 2018-04-23 | 2 days | — | $1K–$15K | 5.5 | ↗ filing |
| Michael Conaway | House | BUY | Spouse | 2018-02-26 | 2 days | — | $1K–$15K | 6.8 | ↗ filing |
| Michael Conaway | House | BUY | Spouse | 2017-11-15 | 2 days | — | $1K–$15K | 8.6 | ↗ filing |
| Lois Frankel | House | SELL | Self | 2017-08-21 | 0 days | — | $1K–$15K 0.3% of NW |
5.5 | ↗ filing |
| Lois Frankel | House | SELL | Self | 2017-08-02 | 0 days | — | $1K–$15K 0.3% of NW |
6.8 | ↗ filing |
| Lois Frankel | House | SELL | Self | 2016-11-23 | 0 days | — | $1K–$15K 0.3% of NW |
8.6 | ↗ filing |
| Michael Conaway | House | SELL | Spouse | 2015-08-07 | 5 days | — | $1K–$15K | 10.6 | ↗ filing |
| Michael Conaway | House | SELL | Spouse | 2015-07-31 | 5 days | — | $1K–$15K | 22.3 | ↗ filing |
| Michael Conaway | House | SELL | Joint | 2015-07-31 | 5 days | — | $1K–$15K | 22.3 | ↗ filing |
| Michael Conaway | House | SELL | Spouse | 2015-07-30 | 5 days | — | $1K–$15K | 75.9 | ↗ filing |
| Michael Conaway | House | SELL | Joint | 2015-07-30 | 5 days | — | $1K–$15K | 75.9 | ↗ filing |
| Lois Frankel | House | BUY | Self | 2015-05-06 | 0 days | — | $1K–$15K 0.3% of NW |
10.6 | ↗ filing |
| Lois Frankel | House | BUY | Self | 2015-04-01 | 0 days | — | $1K–$15K 0.3% of NW |
15.7 | ↗ filing |
| Lois Frankel | House | BUY | Self | 2015-01-28 | 0 days | — | $1K–$15K 0.3% of NW |
22.3 | ↗ filing |
| Lois Frankel | House | BUY | Self | 2015-01-21 | 0 days | — | $1K–$15K 0.3% of NW |
40.4 | ↗ filing |
| Lois Frankel | House | BUY | Self | 2015-01-07 | 0 days | — | $1K–$15K 0.3% of NW |
75.9 | ↗ filing |
Corporate insiders · SEC Form 4 Insider Activity
What the company's own officers and directors did in NOC — open-market purchases and sales from SEC Form 4 filings (option exercises, grants and tax withholding are excluded). This is context for the congressional activity above, never a buy/sell signal, and the two datasets are kept separate on purpose. Does convergence mean anything? →
11
Congress trades with insider convergence
10
…with insider divergence
212
Insider open-market trades
Of the congressional trades in NOC, 11 coincided with corporate insiders moving the same way within 60 days, and 10 with insiders moving the opposite way. This is co-occurrence only — whether it carries any edge is tested honestly on the convergence page.
| Date | Insider | Role | Type | Size | Source |
|---|---|---|---|---|---|
| 2026-11-02 | WELSH MARK A III | Director | SELL 10b5-1 | $4K | ↗ EDGAR |
| 2026-11-02 | WELSH MARK A III | Director | SELL 10b5-1 | $11K | ↗ EDGAR |
| 2026-11-02 | WELSH MARK A III | Director | SELL 10b5-1 | $11K | ↗ EDGAR |
| 2026-11-02 | WELSH MARK A III | Director | SELL 10b5-1 | $28K | ↗ EDGAR |
| 2026-11-02 | WELSH MARK A III | Director | SELL 10b5-1 | $557 | ↗ EDGAR |
| 2026-08-03 | WELSH MARK A III | Director | SELL 10b5-1 | $4K | ↗ EDGAR |
| 2026-08-03 | WELSH MARK A III | Director | SELL 10b5-1 | $10K | ↗ EDGAR |
| 2026-08-03 | WELSH MARK A III | Director | SELL 10b5-1 | $6K | ↗ EDGAR |
| 2026-08-03 | WELSH MARK A III | Director | SELL 10b5-1 | $17K | ↗ EDGAR |
| 2026-08-03 | WELSH MARK A III | Director | SELL 10b5-1 | $5K | ↗ EDGAR |
| 2026-08-03 | WELSH MARK A III | Director | SELL 10b5-1 | $3K | ↗ EDGAR |
| 2026-08-03 | WELSH MARK A III | Director | SELL 10b5-1 | $1K | ↗ EDGAR |
| 2026-08-03 | WELSH MARK A III | Director | SELL 10b5-1 | $1K | ↗ EDGAR |
| 2026-08-03 | WELSH MARK A III | Director | SELL 10b5-1 | $1K | ↗ EDGAR |
| 2026-08-03 | WELSH MARK A III | Director | SELL 10b5-1 | $2K | ↗ EDGAR |
| 2026-05-04 | WELSH MARK A III | Director | SELL 10b5-1 | $567 | ↗ EDGAR |
| 2026-05-04 | WELSH MARK A III | Director | SELL 10b5-1 | $3K | ↗ EDGAR |
| 2026-05-04 | WELSH MARK A III | Director | SELL 10b5-1 | $5K | ↗ EDGAR |
| 2026-05-04 | WELSH MARK A III | Director | SELL 10b5-1 | $25K | ↗ EDGAR |
| 2026-05-04 | WELSH MARK A III | Director | SELL 10b5-1 | $2K | ↗ EDGAR |
| 2026-05-04 | WELSH MARK A III | Director | SELL 10b5-1 | $3K | ↗ EDGAR |
| 2026-05-04 | WELSH MARK A III | Director | SELL 10b5-1 | $8K | ↗ EDGAR |
| 2026-05-04 | WELSH MARK A III | Director | SELL 10b5-1 | $1K | ↗ EDGAR |
| 2026-05-04 | WELSH MARK A III | Director | SELL 10b5-1 | $2K | ↗ EDGAR |
| 2026-05-04 | WELSH MARK A III | Director | SELL 10b5-1 | $4K | ↗ EDGAR |
Combined timeline — Congress & insiders
Both sets of trades on one timeline, newest first, so you can see when they lined up. Congress vs ◆ insider.
| Date | Who | Type | Size | |
|---|---|---|---|---|
| ◆ insider | 2026-11-02 | WELSH MARK A III Director 10b5-1 | SELL | $4K |
| ◆ insider | 2026-11-02 | WELSH MARK A III Director 10b5-1 | SELL | $11K |
| ◆ insider | 2026-11-02 | WELSH MARK A III Director 10b5-1 | SELL | $11K |
| ◆ insider | 2026-11-02 | WELSH MARK A III Director 10b5-1 | SELL | $28K |
| ◆ insider | 2026-11-02 | WELSH MARK A III Director 10b5-1 | SELL | $557 |
| ◆ insider | 2026-08-03 | WELSH MARK A III Director 10b5-1 | SELL | $4K |
| ◆ insider | 2026-08-03 | WELSH MARK A III Director 10b5-1 | SELL | $10K |
| ◆ insider | 2026-08-03 | WELSH MARK A III Director 10b5-1 | SELL | $6K |
| ◆ insider | 2026-08-03 | WELSH MARK A III Director 10b5-1 | SELL | $17K |
| ◆ insider | 2026-08-03 | WELSH MARK A III Director 10b5-1 | SELL | $5K |
| ◆ insider | 2026-08-03 | WELSH MARK A III Director 10b5-1 | SELL | $3K |
| ◆ insider | 2026-08-03 | WELSH MARK A III Director 10b5-1 | SELL | $1K |
| ◆ insider | 2026-08-03 | WELSH MARK A III Director 10b5-1 | SELL | $1K |
| ◆ insider | 2026-08-03 | WELSH MARK A III Director 10b5-1 | SELL | $1K |
| ◆ insider | 2026-08-03 | WELSH MARK A III Director 10b5-1 | SELL | $2K |
| ◆ insider | 2026-05-04 | WELSH MARK A III Director 10b5-1 | SELL | $567 |
| ◆ insider | 2026-05-04 | WELSH MARK A III Director 10b5-1 | SELL | $3K |
| ◆ insider | 2026-05-04 | WELSH MARK A III Director 10b5-1 | SELL | $5K |
| ◆ insider | 2026-05-04 | WELSH MARK A III Director 10b5-1 | SELL | $25K |
| ◆ insider | 2026-05-04 | WELSH MARK A III Director 10b5-1 | SELL | $2K |
| ◆ insider | 2026-05-04 | WELSH MARK A III Director 10b5-1 | SELL | $3K |
| ◆ insider | 2026-05-04 | WELSH MARK A III Director 10b5-1 | SELL | $8K |
| ◆ insider | 2026-05-04 | WELSH MARK A III Director 10b5-1 | SELL | $1K |
| ◆ insider | 2026-05-04 | WELSH MARK A III Director 10b5-1 | SELL | $2K |
FAQ Common questions
How much has Congress traded NOC?
27 disclosed buys and 32 sells of NOC (Northrop Grumman Corp.) appear in official congressional financial disclosures.
Is it legal for members of Congress to trade NOC?
Members of Congress may trade stocks but must disclose it under the STOCK Act. QuantCapitol tracks those public disclosures for transparency — nothing here is an accusation of wrongdoing or investment advice.
Where does this data come from?
Official US House Clerk and Senate electronic financial disclosures. Every trade links back to its original filing so you can verify it yourself.